Treatment for hepatitis C in kidney disease patients
Part of Digestive system, Infections clinical trials.
This study tests a new treatment for hepatitis C in people who also have chronic kidney disease. It aims to see if the treatment is safe and effective for this group, including those on dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have chronic kidney disease that is stable (with or without dialysis)
- If you are on hemodialysis, you must have been on it for at least 6 months
- You have a hepatitis C infection (genotype 4) with a high viral load
- Your blood cell counts are within acceptable levels
- You are not pregnant and do not have HIV or hepatitis B
- Your liver enzyme levels are not too high
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests antiviral medicine given around the time of a kidney transplant to prevent hepatitis C infection when the donor has hepatitis C. It may help uninfected recipients stay hepatitis C–free after receiving the kidney.
This study compares two ways to treat hepatitis C: getting treatment at a local clinic near you, or the usual care at a central hospital. It aims to see if treatment at local clinics is safe, effective, and more convenient for patients.
This trial tests whether a very short 4-week course of two hepatitis C drugs (sofosbuvir and glecaprevir-pibrentasvir) can cure hepatitis C in people with early-stage liver disease. The goal is to see if a shorter treatment works as well as longer ones.
This study tests hepatitis C virus (HCV) treatment using medications called sofosbuvir and velpatasvir, with the goal of curing the infection. If you've been treated before and the virus came back, you may be eligible for retreatment with additional medication.
This trial looks at hepatitis C treatment for people whose last antiviral medicines did not fully clear the virus. It may help by testing a study drug approach for people in Pakistan who still have active hepatitis C infection.
This study aims to make hepatitis C treatment simpler and more accessible for people who inject drugs. If you join, you'll receive care that fits your lifestyle and helps cure hep C.
Hear when a new HCV Infection ( Genotype 4) in CKD Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.